Evidence map›Paper›PMID 40835426›Full record

ArticleEndocrine journal2025

Primary aldosteronism increases the risk of urinary stones.

Itsuko Asayama, Masakazu Notsu, Miwa Ota, Masahiro Yamamoto, Keizo Kanasaki

Abstract read
In one paragraph

Article in Endocrine journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Itsuko AsayamaDepartment of Internal Medicine 1, Shimane University Faculty of Medicine, Izumo, Japan.
Masakazu NotsuDepartment of Internal Medicine 1, Shimane University Faculty of Medicine, Izumo, Japan.ORCID http://orcid.org/0000-0002-8326-8154
Miwa OtaDepartment of Internal Medicine 1, Shimane University Faculty of Medicine, Izumo, Japan.
Masahiro YamamotoDepartment of Internal Medicine 1, Shimane University Faculty of Medicine, Izumo, Japan.ORCID http://orcid.org/0000-0003-3859-0125
Keizo KanasakiDepartment of Internal Medicine 1, Shimane University Faculty of Medicine, Izumo, Japan.ORCID http://orcid.org/0000-0002-9563-502X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Urinary calcium excretion increases in patients with primary aldosteronism (PA) and is associated with higher prevalence of renal stones formations. However, it remains unclear whether the prevalence of urinary stones is higher in patients with PA than in those with nonfunctioning adrenal tumors (NF). We aimed to investigate whether the prevalence of urinary stones is higher in patients with PA than in those without PA. The study was conducted between April 2006 and March 2021. We enrolled 140 PA and 144 NF patients. Urinary stones and renal calcifications were evaluated through patient history or CT findings. Serum and urinary parameters, presence of urinary stones and/or calcifications, were evaluated in both groups. Logistic regression analyses were performed, adjusting for relevant variables. Compared to the NF group, the PA group was younger, and displayed significantly higher blood pressure, aldosterone-rennin ratio, eGFR, serum Na, urinary Ca excretion, and intact PTH levels. In contrast, serum K, Ca and creatinine levels were lower in PA group. PA patients also demonstrated a lower prevalence of diabetes, smaller adrenal tumor size, and a lower percentage of smokers compared to the NF group. Urinary stones and renal calcifications were significantly more frequent in the PA group. Logistic regression confirmed PA as an independent risk factor for urinary stones, regardless of age, sex, BMI, eGFR, serum and urinary calcium, and intact PTH. PA is an independent risk factor for urinary stones and renal calcifications.

Indexed as

Adrenal Gland NeoplasmsHyperaldosteronismUrinary CalculiAdultAgedFemaleHumansMaleMiddle AgedPrevalenceRisk FactorsNon-functioning adrenal tumorPrimary aldosteronismRenal calcificationUrinary stone

Identifiers

PMID40835426
PMCPMC12702668

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.